Supriya Roy
Madhav Chanchani
Supriya Roy
Madhav Chanchani
In a crowded market comprising conglomerates, MNCs and cash-rich startups, 1mg has spent the last year improving its supply chain and expanding. The Tata Digital-owned company is now raising more capital, but will it be enough to take on the heavily funded Pharmeasy and Reliance-backed Netmeds?
July 27, 2022
11 MINS READAbout two years ago, just when the first wave of the Covid-19 pandemic sparked a spike in demand for deliveries by online pharmacy players, 1mg Technologies hit the market to raise a new round of funding.
When it started out, 1mg was not meant to be an online pharma company. At least, that was not founder Prashant Tandon’s and then co-founder Sameer Maheshwari’s original business idea back in 2011. The startup was an offshoot of e-commerce platform Healthkart, best known for selling supplements. It was known as Healthkartplus – an online marketplace for health devices, personal care, fitness and nutrition supplements, sports nutrition, eye-care and so on, having tie-ups with top distributors and retailers in different cities.
But in 2015, Tandon, a McKinsey consultant with an MBA from Stanford, decided to demerge the business.
AgriTech
Premium Reads
By Vidhya Sivaramakrishnan
Analysis
Premium Reads
By Raghav Mahobe
Insurtech
Premium Reads
By Sohini Mitter
Analysis
Premium Reads
By Gaurav Tyagi
11 Min Read
By Vidhya Sivaramakrishnan
13 Min Read
By Raghav Mahobe
9 Min Read
By Sohini Mitter
12 Min Read
By Gaurav Tyagi
9 Min Read
By Nikhil Patwardhan
9 Min Read
By Pranav Balakrishnan